ProfileGDS5822 / ILMN_2590811
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 45% 2% 33% 10% 16% 10% 7% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 119.745
GSM1276600PDAC Late Ablation Control 27.92
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.233
GSM1276603PDAC Late Ablation 28.710
GSM1276604PDAC Late Ablation 310.616
GSM1303940PDAC Late Ablation_anti-CTLA4 19.710
GSM1303941PDAC Late Ablation_anti-CTLA4 2
GSM1303942PDAC Late Ablation_anti-CTLA4 35.17